Offline Showroom in USA
Post Offer Free
MOSINTER GROUP LIMITED
MOSINTER GROUP LIMITED  

Gold Index: 82941

You are here: home  > Pharmaceutical Chemicals API  > Antibiotic Drugs API  > Favipiravir CAS 259793-96-9 T-705 Avigan

Favipiravir CAS 259793-96-9 T-705 Avigan 

Payment Terms: T/T,L/C,WU 
Place of Origin: Zhejiang, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Model No.: C5H4FN3O2
Production Capacity: 50 Kilogram/Year
Delivery Date: within 7 days
Molecular Formul: C5H4FN3O2
Molecular Weight: 157.10493
Means of Transport: Ocean,Land,Air
Packing: According to the request of...
Brand: MOSINTER
CAS NO.: 259793-96-9

The drug appears to be effective in a mouse model of Ebola virus disease, but its efficacy against human Ebola infection is unproved.

Favipiravir CAS: 259793-96-9 

Molecular Formula:

C5H4FN3O2

Molecular Weight:

157.10493

Product Name:

6-Fluoro-3-hydroxypyrazine-2-carboxamide


Favipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses. Like some other experimental antiviral drug (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. Favipiravir is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated.

 

The mechanism of its actions is thought to be related to the selective inhibition of viral RNA-dependent RNA polymerase. Favipiravir does not inhibit RNA or DNA synthesis in mammalian cells and is not toxic to them.

 

In 2014, favipiravir was approved in Japan for stockpiling against influenza pandemics.

 

Ebola virus disease

The drug appears to be effective in a mouse model of Ebola virus disease, but its efficacy against human Ebola infection is unproved. During the 2014 West Africa Ebola virus outbreak, it was reported that a French nurse who contracted Ebola while volunteering for MSF in Liberia recovered after receiving a course of favipiravir. A clinical trial investigating the use of favipiravir against Ebola virus disease was started in Guéckédou, Guinea, during December 2014. Preliminary results showed a decrease in mortality rate in patients with low-to moderate levels of Ebola virus in the blood, but no effect on patients with high levels of the virus, a group at a higher risk of death.

bigPhoto
skype Mr. Fedor

Tel: +86-574-89212210
Fax: +86-574-89212215
Mobile: 86- 189 8930 5995
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Company Info

MOSINTER GROUP LIMITED [China (Mainland)]

Offline Showroom in USA

Business Type:Manufacturer, Trading Company
City: Ningbo
Province/State: Zhejiang
Country/Region: China (Mainland)

Follow Us: Follow us on facebook Follow us on linkedin

Fedor:   skype

You May Like: